Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer

Post time 2023-4-26 19:03:25

journal：Journal of Medicinal Chemistry

Authors：Woong Sub Byun; Hyewon Lim; Junhwa Hong; Eun Seo Bae; Seok Beom Lee; Younggwan Kim; Jeeyeon Lee; Sang Kook Lee; Suckchang Hong

Published date：2023-2-23

DOI：10.1021/acs.jmedchem.2c01115

Article link：http://dx.doi.org/10.1021/acs.jmedchem.2c01115

Article Source：American Chemical Society (ACS)。

Remark：

Post time 2023-4-26 19:03:26

: This post has been completed
Completed attachments will be deleted within 24 hours.

[ACS] Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[ACS] Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[ACS] Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer